These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7834962)

  • 21. Pharmacokinetic drug interaction studies must consider pharmacological heterogeneity, use of repeated dosing, and translation into a message understandable to practicing clinicians.
    de Leon J; Spina E; Diaz FJ
    J Clin Psychopharmacol; 2009 Jun; 29(3):201-5. PubMed ID: 19440070
    [No Abstract]   [Full Text] [Related]  

  • 22. The current state of knowledge on age, sex, and their interactions on clinical pharmacology.
    Schwartz JB
    Clin Pharmacol Ther; 2007 Jul; 82(1):87-96. PubMed ID: 17495875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chirality--a new era of therapeutics.
    Agrawal YK; Bhatt HG; Raval HG; Oza PM; Gogoi PJ
    Mini Rev Med Chem; 2007 May; 7(5):451-60. PubMed ID: 17504180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chirality and its importance in drug development.
    Campbell DB; Wilson K
    Biochem Soc Trans; 1991 Apr; 19(2):472-5. PubMed ID: 1889635
    [No Abstract]   [Full Text] [Related]  

  • 25. Dosage regimen design: a pharmacokinetic approach.
    Thompson GA
    J Clin Pharmacol; 1992 Mar; 32(3):210-4. PubMed ID: 1564124
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical pharmacokinetics: current requirements and future perspectives from a regulatory point of view.
    Shah RR
    Xenobiotica; 1993 Nov; 23(11):1159-93. PubMed ID: 8310705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacological and toxicological significance of the stereochemistry of drug disposition.
    Caldwell J; Winter SM; Hutt AJ
    Xenobiotica; 1988 Jan; 18 Suppl 1():59-70. PubMed ID: 3344590
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmaceutical applications of AC biosusceptometry.
    Corá LA; Américo MF; Romeiro FG; Oliveira RB; Miranda JR
    Eur J Pharm Biopharm; 2010 Jan; 74(1):67-77. PubMed ID: 19482083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods.
    Coelho MM; Fernandes C; Remião F; Tiritan ME
    Molecules; 2021 May; 26(11):. PubMed ID: 34070985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Essential pharmacokinetic information for drug dosage decisions: a concise visual presentation in the drug label.
    Menon-Andersen D; Yu B; Madabushi R; Bhattaram V; Hao W; Uppoor RS; Mehta M; Lesko L; Temple R; Stockbridge N; Laughren T; Gobburu JV
    Clin Pharmacol Ther; 2011 Sep; 90(3):471-4. PubMed ID: 21796114
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of nanotechnology in pharmaceutical product development.
    Devalapally H; Chakilam A; Amiji MM
    J Pharm Sci; 2007 Oct; 96(10):2547-65. PubMed ID: 17688284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of physiologically based pharmacokinetic modeling for assessment of drug-drug interactions.
    Baneyx G; Fukushima Y; Parrott N
    Future Med Chem; 2012 Apr; 4(5):681-93. PubMed ID: 22458685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The importance of biopharmaceutics in pharmaceutical education.
    Mezei M
    Pharmazie; 1971 Nov; 26(11):656-8. PubMed ID: 5154315
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug-drug interactions (author's transl)].
    Forth W
    Arzneimittelforschung; 1976; 26(1A):108-14. PubMed ID: 7276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coupling biorelevant dissolution methods with physiologically based pharmacokinetic modelling to forecast in-vivo performance of solid oral dosage forms.
    Otsuka K; Shono Y; Dressman J
    J Pharm Pharmacol; 2013 Jul; 65(7):937-52. PubMed ID: 23738721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Administration of medicines. Part 2: Pharmacology.
    Jordan S; Griffiths H; Griffith R
    Nurs Stand; 2003 Oct 1-7; 18(3):45-54; quiz 55-6. PubMed ID: 14595964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical evaluation of therapeutic drug monitoring].
    Kohno H
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():351-5. PubMed ID: 15658336
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetic changes in the elderly.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1987 Mar; 9(3):161-6. PubMed ID: 3298892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.